Benchmarking In Silico Tools for Cysteine p K a Prediction
Accurate estimation of the p 's of cysteine residues in proteins could inform targeted approaches in hit discovery. The p of a targetable cysteine residue in a disease-related protein is an important physiochemical parameter in covalent drug discovery, as it influences the fraction of nucleophi...
Gespeichert in:
Veröffentlicht in: | Journal of chemical information and modeling 2023-04, Vol.63 (7), p.2170-2180 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Accurate estimation of the p
's of cysteine residues in proteins could inform targeted approaches in hit discovery. The p
of a targetable cysteine residue in a disease-related protein is an important physiochemical parameter in covalent drug discovery, as it influences the fraction of nucleophilic thiolate amenable to chemical protein modification. Traditional structure-based
tools are limited in their predictive accuracy of cysteine p
's relative to other titratable residues. Additionally, there are limited comprehensive benchmark assessments for cysteine p
predictive tools. This raises the need for extensive assessment and evaluation of methods for cysteine p
prediction. Here, we report the performance of several computational p
methods, including single-structure and ensemble-based approaches, on a diverse test set of experimental cysteine p
's retrieved from the PKAD database. The dataset consisted of 16 wildtype and 10 mutant proteins with experimentally measured cysteine p
values. Our results highlight that these methods are varied in their overall predictive accuracies. Among the test set of wildtype proteins evaluated, the best method (MOE) yielded a mean absolute error of 2.3 p
units, highlighting the need for improvement of existing p
methods for accurate cysteine p
estimation. Given the limited accuracy of these methods, further development is needed before these approaches can be routinely employed to drive design decisions in early drug discovery efforts. |
---|---|
ISSN: | 1549-9596 1549-960X |
DOI: | 10.1021/acs.jcim.3c00004 |